JAK2V617F: more than a clonal marker?

被引：0
|
作者：
Tefferi, Ayalew [1 ]
机构：
[1] Mayo Clin, Dept Med, Div Hematol, Rochester, MN 55905 USA
来源：
LEUKEMIA & LYMPHOMA | 2009年 / 50卷 / 02期
关键词：
POLYCYTHEMIA-VERA; ESSENTIAL THROMBOCYTHEMIA; PRIMARY MYELOFIBROSIS; ALLELE BURDEN; MUTATIONS; THERAPY;
D O I：
10.1080/10428190902717059
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：154 / 155
页数：2
相关论文
共 50 条
  • [21] TNFα facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms
    Fleischman, Angela G.
    Aichberger, Karl J.
    Luty, Samuel B.
    Bumm, Thomas G.
    Petersen, Curtis L.
    Doratotaj, Shirin
    Vasudevan, Kavin B.
    LaTocha, Dorian H.
    Yang, Fei
    Press, Richard D.
    Loriaux, Marc M.
    Pahl, Heike L.
    Silver, Richard T.
    Agarwal, Anupriya
    O'Hare, Thomas
    Druker, Brian J.
    Bagby, Grover C.
    Deininger, Michael W.
    BLOOD, 2011, 118 (24) : 6392 - 6398
  • [22] Visual screening for JAK2V617F mutation by a disposable dipstick
    Konstantou, Jessica K.
    Iliadi, Alexandra C.
    Ioannou, Penelope C.
    Christopoulos, Theodore K.
    Anagnostopoulos, Nikolaos I.
    Kanavakis, Emmanuel
    Traeger-Synodinos, Jan
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2010, 397 (05) : 1911 - 1916
  • [23] Clinical correlates of JAK2V617F presence or allele burden in myeloproliferative neoplasms:: a critical reappraisal
    Vannucchi, A. M.
    Antonioli, E.
    Guglielmelli, P.
    Pardanani, A.
    Tefferi, A.
    LEUKEMIA, 2008, 22 (07) : CP5 - 1307
  • [24] Myeloproliferative neoplasms 5 years after discovery of JAK2V617F: what is the impact of JAK2 inhibitor therapy?
    Tibes, Raoul
    Mesa, Ruben A.
    LEUKEMIA & LYMPHOMA, 2011, 52 (07) : 1178 - 1187
  • [25] Impact of JAK2V617F Mutational Status on Phenotypic Features in Essential Thrombocythemia and Primary Myelofibrosis
    Yonal, Ipek
    Daglar-Aday, Aynur
    Akadam-Teker, Basak
    Yilmaz, Ceylan
    Nalcaci, Meliha
    Yavuz, Akif Selim
    Sargin, Fatma Deniz
    TURKISH JOURNAL OF HEMATOLOGY, 2016, 33 (02) : 94 - 101
  • [26] JAK2V617F allele burden in patients with myeloproliferative neoplasms
    Alshemmari, Salem H.
    Rajaan, Reshmi
    Ameen, Reem
    Al-Drees, Mohammad A.
    Almosailleakh, Marwa R.
    ANNALS OF HEMATOLOGY, 2014, 93 (05) : 791 - 796
  • [27] Cigarette smoke stimulates clonal expansion of Jak2V617F and Tet2-/- cells
    Ramanathan, Gajalakshmi
    Chen, Jane H.
    Mehrotra, Nitya
    Trieu, Tiffany
    Huang, Aaron
    Mas, Eduard
    Mena, Jessica Monterrosa E.
    Bliss, Bishop
    Herman, David A.
    Kleinman, Michael T.
    Fleischman, Angela G.
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [28] JAK2V617F drives gut microbiota differences in patients with myeloproliferative neoplasms
    Eickhardt-Dalboge, Christina Schjellerup
    Nielsen, Henrik V.
    Fuursted, Kurt
    Stensvold, Christen Rune
    Andersen, Lee O' Brien
    Lilje, Berit
    Larsen, Morten Kranker
    Kjaer, Lasse
    Christensen, Sarah Friis
    Knudsen, Trine Alma
    Skov, Vibe
    Sorensen, Anders Lindholm
    Ellervik, Christina
    Olsen, Lars Ronn
    Christensen, Jens Jorgen Elmer
    Nielsen, Xiaohui Chen
    Hasselbalch, Hans Carl
    Ingham, Anna Cacilia
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 112 (05) : 776 - 787
  • [29] Hemichorea in a patient with JAK2V617F blood cells
    Lew, Jane
    Frucht, Steven J.
    Kremyanskaya, Marina
    Hoffman, Ronald
    Mascarenhas, John
    BLOOD, 2013, 121 (07) : 1239 - 1240
  • [30] Correlative study between the JAK2V617F mutation and thrombosis in patients with myeloproliferative neoplasm
    Li, Z. C.
    Fu, H. J.
    Wang, Z. M.
    Yang, S.
    Xu, H. Z.
    GENETICS AND MOLECULAR RESEARCH, 2016, 15 (03):
12345